Top 5 COVID Stocks for Investment in December 2020

Investors have options with stocks as we enter the second phase of COVID-era December. What can we expect from 2021? A devastating phase of 2020 is coming to an end. The hard times of the COVID-19 era are about to end soon with vaccine candidates around the edge. With much happening on the development and […]

Why Socket Mobile, Inc. (NASDAQ: SCKT) jumped in the pre-market session?

BLNK

In the pre-market session, the stock of Socket Mobile, Inc. (NASDAQ: SCKT) rose almost 52 percent to $4.06, amid no reports or press releases from the Computerhardware business. So, what is the question in your mind? And why is the stock breaking barriers today? Here is the last update for curious investors to learn about Socket Mobile, Inc. On November 18,2020, […]

Here is why Google Inc (GOOG) Services fumbled in the Early morning on Monday.

Google services like Gmail, YouTube halted temporarily on a Monday morning. However, there is no such update from the Company regarding this cessation. We will update this article as soon as any report or information is unveiled. Update: 7:30 am Google service including google analytics, gmail and other seems to be online again now still […]

Here’s why Alexion Pharmaceuticals (ALXN) sky-rocketed in the pre-market session

AVGR Stock

Alexion Pharmaceuticals stocks surged 33.09% to $161.1 in the pre-market session following a report that AstraZeneca and Alexion Pharmaceuticals (ALXN) have signed a formal deal about the purchase of Alexion by AstraZeneca. As demonstrated by American Depositary Receipts (ADRs), for each Alexion share, Alexion shareholders would earn $60 in cash and 2,1243 AstraZeneca American Depositary […]

No matter how Codexis (Nasdaq: CDXS) shares jumped in the late session on Friday

SFT Stock

A leading protein engineering firm, Codexis (Nasdaq: CDXS), stock in postmarket trade has grown 14.17% to $7.001. There does not seem to be any business news that today prompted the price of Codexis share to surge, and investors would want to take this as a signal for warning. However, on December 02, 2020, the pricing […]

Is that why Aerpio Pharmaceuticals (Nasdaq: ARPO) stock plunged in the AH session?

MTTR

Aerpio Pharmaceuticals, (Nasdaq: ARPO), the stock dipped -40.89% to $1.33 in the After-market session, as Razuprotafib met its primary efficacy endpoint at 28 days in Aerpio’s double-blind Phase 2 trial in patients with elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. Compared to the monotherapy group, razuprotafib did not show any statistically significant […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.